Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,346,085
-$214,668 QoQ
Shares Held
19,942
-52.8% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#85
of 211 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. ANAB ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,729 | $21,224,776 | |
| 2 | INCY |
Incyte Corp
|
168,818 | $19,137,208 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
59,492 | $14,335,787 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,953 | $11,817,953 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
17,562 | $5,551,172 | |
| 6 | ACAD |
Acadia Pharmaceuticals Inc
|
167,893 | $4,247,692 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,634 | $4,104,243 | |
| 8 | INVA |
Innoviva, Inc.
|
165,115 | $3,749,761 |
All Filings in ANAB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,346,085 | 19,942 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,560,753 | 28,142 | Shares | Sole | 2026-05-13 | |
| 2024-12-31 | $383,894 | 28,995 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $971,330 | 28,995 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $717,594 | 28,635 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $644,857 | 28,635 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $613,018 | 28,619 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $513,994 | 28,619 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $582,110 | 28,619 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $585,715 | 26,917 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $809,365 | 26,117 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $666,067 | 26,110 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $479,280 | 23,610 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $556,870 | 22,509 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $876,013 | 25,209 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $908,899 | 33,514 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $511,184 | 19,714 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $388,180 | 18,013 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $275,543 | 12,816 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $259,864 | 17,618 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $393,585 | 17,618 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $244,745 | 17,321 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||